A nuclear localization sequence endows human pancreatic ribonuclease with cytotoxic activity

被引:51
作者
Bosch, M
Benito, A
Ribó, M
Puig, T
Beaumelle, B
Vilanova, M
机构
[1] Univ Girona, Fac Ciencies, Dept Biol, Lab Engn Prot, E-17071 Girona, Spain
[2] Univ Montpellier 2, Dept Biol Sante, CNRS, UMR 5539, F-34095 Montpellier 05, France
关键词
D O I
10.1021/bi035729+
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Some members of the ribonuclease superfamily, such as Onconase, are cytotoxic to cancer cells. This is not the case for human pancreatic ribonuclease. This lack of cytotoxicity is probably a result of the inhibition exerted by the cytosolic ribonuclease inhibitor once the protein has reached the cytosol. Until now, all cytotoxic human pancreatic ribonuclease variants have been described as being resistant to the inhibitor. Here, we report on the characterization of a cytotoxic variant of human pancreatic ribonuclease which has an Arg triplet introduced onto one of its surface-exposed loops. Despite its sensitivity to the inhibitor, this variant, called PE5, was only 5-15 times less cytotoxic than Onconase. When it was taken up by cells, it was only observed within late compartments of the endocytic pathway, probably because the number of molecules transported to the cytosol was too small to allow their visualization. Nuclear import assays showed that the Arg triplet endows PE5 with a nuclear localization signal. In these experiments, PE5 was efficiently transported to the nucleus where it was initially localized in the nucleolus. Although the Arc, introduction modified the net charge of the protein and somehow impaired recognition by the cytosolic inhibitor, control variants, which had the same number of charges or were not recognized by the inhibitor, were not toxic. We concluded that targeting a ribonuclease to the nucleus results in cytotoxicity. This effect is probably due to ribonuclease interference with rRNA processing and ribosome assembly within the nucleolus.
引用
收藏
页码:2167 / 2177
页数:11
相关论文
共 41 条
[1]   Involvement of ATP-dependent Pseudomonas exotoxin translocation from a late recycling compartment in lymphocyte intoxication procedure [J].
Alami, M ;
Taupiac, MP ;
Reggio, H ;
Bienvenüe, A ;
Beaumelle, B .
MOLECULAR BIOLOGY OF THE CELL, 1998, 9 (02) :387-402
[2]   Ricin A chain can transport unfolded dihydrofolate reductase into the cytosol [J].
Beaumelle, B ;
Taupiac, MP ;
Lord, JM ;
Roberts, LM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (35) :22097-22102
[3]   Role of the N terminus in RNase a homologues: Differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity [J].
Boix, E ;
Wu, YN ;
Vasandani, VM ;
Saxena, SK ;
Ardelt, W ;
Ladner, J ;
Youle, RJ .
JOURNAL OF MOLECULAR BIOLOGY, 1996, 257 (05) :992-1007
[4]   Preparation of potent cytotoxic ribonucleases by cationization: Enhanced cellular uptake and decreased interaction with ribonuclease inhibitor by chemical modification of carboxyl groups [J].
Futami, J ;
Maeda, T ;
Kitazoe, M ;
Nukui, E ;
Tada, H ;
Seno, M ;
Kosaka, M ;
Yamada, H .
BIOCHEMISTRY, 2001, 40 (25) :7518-7524
[5]   Interaction of human pancreatic ribonuclease with human ribonuclease inhibitor - Generation of inhibitor-resistant cytotoxic variants [J].
Gaur, D ;
Swaminathan, S ;
Batra, JK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (27) :24978-24984
[6]   CALCULATION OF PROTEIN EXTINCTION COEFFICIENTS FROM AMINO-ACID SEQUENCE DATA [J].
GILL, SC ;
VONHIPPEL, PH .
ANALYTICAL BIOCHEMISTRY, 1989, 182 (02) :319-326
[7]   The endocytic pathway: A mosaic of domains [J].
Gruenberg, J .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (10) :721-730
[8]   Ribonuclease inhibitor as an intracellular sentry [J].
Haigis, MC ;
Kurten, EL ;
Raines, RT .
NUCLEIC ACIDS RESEARCH, 2003, 31 (03) :1024-1032
[9]   Secretory ribonucleases are internalized by a dynamin-independent endocytic pathway [J].
Haigis, MC ;
Raines, RT .
JOURNAL OF CELL SCIENCE, 2003, 116 (02) :313-324
[10]   Clathrin-dependent or not: Is it still the question? [J].
Johannes, L ;
Lamaze, C .
TRAFFIC, 2002, 3 (07) :443-451